Dizhe Pharmaceutical (688192.SH) announced that the restricted shares for circulation in this listing are part of the company's initial public offering...
According to the Zhichun Finance APP, Dize Pharmaceutical (688192.SH) announced that the restricted shares being circulated in this listing are those held by certain shareholders before the company's initial public offering. This involves 1 restricted shareholder, Jiangsu Wuxi Dize Enterprise Management Partnership (Limited Partnership), referred to as "Wuxi Dize," who holds approximately 57.4518 million restricted shares, accounting for 13.76% of the company's total current share capital. The restriction period is three full accounting years from the date the company's stocks are listed. The lock-in period is about to expire, and the above restricted shares will be available for trading starting from January 9, 2025.